vs
NATIONAL HEALTHCARE CORP（NHC）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
NATIONAL HEALTHCARE CORP的季度营收约是ROGERS CORP的1.9倍（$386.5M vs $200.5M），NATIONAL HEALTHCARE CORP净利率更高（6.4% vs 2.2%，领先4.2%），ROGERS CORP同比增速更快（5.2% vs 4.6%），NATIONAL HEALTHCARE CORP自由现金流更多（$6.4M vs $1.1M），过去两年NATIONAL HEALTHCARE CORP的营收复合增速更高（14.0% vs -3.3%）
HCA Healthcare是1968年成立的美国营利性医疗服务运营商，总部位于田纳西州纳什维尔。截至2020年5月，该公司在全美20个州及英国持有并运营186家医院，还有约2400个医疗服务网点，涵盖手术中心、独立急诊室、紧急护理中心及医师诊所，2024年位列美国财富500强第61位。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
NHC vs ROG — 直观对比
营收规模更大
NHC
是对方的1.9倍
$200.5M
营收增速更快
ROG
高出0.6%
4.6%
净利率更高
NHC
高出4.2%
2.2%
自由现金流更多
NHC
多$5.3M
$1.1M
两年增速更快
NHC
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.5M | $200.5M |
| 净利润 | $24.8M | $4.5M |
| 毛利率 | — | 32.2% |
| 营业利润率 | 8.6% | — |
| 净利率 | 6.4% | 2.2% |
| 营收同比 | 4.6% | 5.2% |
| 净利润同比 | 308.6% | 421.4% |
| 每股收益（稀释后） | $1.58 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NHCROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $386.5M | $201.5M | ||
| Q3 25 | $382.7M | $216.0M | ||
| Q2 25 | $374.9M | $202.8M | ||
| Q1 25 | $373.7M | $190.5M | ||
| Q4 24 | $369.4M | $192.2M | ||
| Q3 24 | $340.2M | $210.3M | ||
| Q2 24 | $300.7M | $214.2M |
净利润NHCROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $24.8M | $4.6M | ||
| Q3 25 | $39.2M | $8.6M | ||
| Q2 25 | $23.7M | $-73.6M | ||
| Q1 25 | $32.2M | $-1.4M | ||
| Q4 24 | $6.1M | $-500.0K | ||
| Q3 24 | $42.8M | $10.7M | ||
| Q2 24 | $26.8M | $8.1M |
毛利率NHCROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 31.6% | ||
| Q1 25 | — | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 34.1% |
营业利润率NHCROG
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 3.5% | ||
| Q3 25 | 7.9% | 7.3% | ||
| Q2 25 | 9.1% | -33.3% | ||
| Q1 25 | 8.2% | -0.2% | ||
| Q4 24 | 7.8% | -6.6% | ||
| Q3 24 | 6.7% | 6.9% | ||
| Q2 24 | 7.5% | 5.3% |
净利率NHCROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | 6.4% | 2.3% | ||
| Q3 25 | 10.3% | 4.0% | ||
| Q2 25 | 6.3% | -36.3% | ||
| Q1 25 | 8.6% | -0.7% | ||
| Q4 24 | 1.6% | -0.3% | ||
| Q3 24 | 12.6% | 5.1% | ||
| Q2 24 | 8.9% | 3.8% |
每股收益（稀释后）NHCROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $1.58 | $0.20 | ||
| Q3 25 | $2.50 | $0.48 | ||
| Q2 25 | $1.52 | $-4.00 | ||
| Q1 25 | $2.07 | $-0.08 | ||
| Q4 24 | $0.38 | $-0.04 | ||
| Q3 24 | $2.73 | $0.58 | ||
| Q2 24 | $1.73 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $92.8M | $195.8M |
| 总债务越低越好 | $40.0M | — |
| 股东权益账面价值 | $1.1B | $1.2B |
| 总资产 | $1.5B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.04× | — |
8季度趋势，按日历期对齐
现金及短期投资NHCROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $92.8M | $197.0M | ||
| Q3 25 | $130.6M | $167.8M | ||
| Q2 25 | $111.0M | $157.2M | ||
| Q1 25 | $90.4M | $175.6M | ||
| Q4 24 | $76.1M | $159.8M | ||
| Q3 24 | $84.8M | $146.4M | ||
| Q2 24 | $136.2M | $119.9M |
总债务NHCROG
| Q1 26 | — | — | ||
| Q4 25 | $40.0M | — | ||
| Q3 25 | $73.1M | — | ||
| Q2 25 | $110.0M | — | ||
| Q1 25 | $134.0M | — | ||
| Q4 24 | $137.0M | — | ||
| Q3 24 | $147.0M | — | ||
| Q2 24 | — | — |
股东权益NHCROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $980.2M | $1.3B | ||
| Q3 24 | $983.5M | $1.3B | ||
| Q2 24 | $945.8M | $1.3B |
总资产NHCROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.6B | $1.5B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.5B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.3B | $1.5B |
负债/权益比NHCROG
| Q1 26 | — | — | ||
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.8M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $6.4M | $1.1M |
| 自由现金流率自由现金流/营收 | 1.7% | 0.5% |
| 资本支出强度资本支出/营收 | 2.7% | 2.3% |
| 现金转化率经营现金流/净利润 | 0.68× | 1.29× |
| 过去12个月自由现金流最近4个季度 | $148.6M | $70.1M |
8季度趋势，按日历期对齐
经营现金流NHCROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $16.8M | $46.9M | ||
| Q3 25 | $66.2M | $28.9M | ||
| Q2 25 | $62.8M | $13.7M | ||
| Q1 25 | $39.3M | $11.7M | ||
| Q4 24 | $12.8M | $33.7M | ||
| Q3 24 | $34.2M | $42.4M | ||
| Q2 24 | $50.7M | $22.9M |
自由现金流NHCROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $6.4M | $42.2M | ||
| Q3 25 | $56.5M | $21.2M | ||
| Q2 25 | $52.6M | $5.6M | ||
| Q1 25 | $33.1M | $2.1M | ||
| Q4 24 | $4.6M | $18.3M | ||
| Q3 24 | $28.6M | $25.2M | ||
| Q2 24 | $42.8M | $8.8M |
自由现金流率NHCROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 1.7% | 20.9% | ||
| Q3 25 | 14.8% | 9.8% | ||
| Q2 25 | 14.0% | 2.8% | ||
| Q1 25 | 8.9% | 1.1% | ||
| Q4 24 | 1.3% | 9.5% | ||
| Q3 24 | 8.4% | 12.0% | ||
| Q2 24 | 14.2% | 4.1% |
资本支出强度NHCROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 2.7% | 2.3% | ||
| Q3 25 | 2.5% | 3.6% | ||
| Q2 25 | 2.7% | 4.0% | ||
| Q1 25 | 1.6% | 5.0% | ||
| Q4 24 | 2.2% | 8.0% | ||
| Q3 24 | 1.7% | 8.2% | ||
| Q2 24 | 2.6% | 6.6% |
现金转化率NHCROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | 0.68× | 10.20× | ||
| Q3 25 | 1.69× | 3.36× | ||
| Q2 25 | 2.65× | — | ||
| Q1 25 | 1.22× | — | ||
| Q4 24 | 2.10× | — | ||
| Q3 24 | 0.80× | 3.96× | ||
| Q2 24 | 1.89× | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NHC
| Inpatient Services Segment | $333.7M | 86% |
| Homecare Services Segment | $40.0M | 10% |
| Other | $11.2M | 3% |
| National | $1.6M | 0% |
ROG
暂无分部数据
